Conference Coverage

ERAS reduced opioid use, improved same-day discharge after gyn surgery

View on the News

Monitor for unintended ERAS consequences

The ERAS pathway described by Dr. Carter-Brooks embraces the core tenets of enhanced recovery, including standardized patient education, multimodal analgesia, and predefined postoperative metrics, according to invited discussant Mark Walters, MD.

Dr. Mark Walters

Dr. Mark Walters

“They documented reduced patient stays and excellent patient satisfaction when they introduced these deliberate and systematic performance improvement practices,” he said. “But implementing these protocols doesn’t happen in a vacuum.”

In fact, systematic culture change requires the involvement of surgeons, nurses, anesthesiologists, and administrative staff, Dr. Walters added.

“Additionally, such significant behavioral changes inevitably result in unintended consequences that must be carefully documented to learn how to mitigate harm in future patients,” he said.

Dr. Walters is professor and vice chair of gynecology in the Center of Urogynecology and Reconstructive Pelvic Surgery, department of obstetrics and gynecology at the Cleveland Clinic. He is a consultant and teacher for Coloplast.


 

REPORTING FROM SGS 2018


“For the preoperative appointment we really spend about 15-30 minutes on education and expectations and prepare the patient to go home. We also encourage them to be advocates and stakeholders in their own recovery, and ... we think that has significantly improved our patients wanting to go home the day of surgery,” she said.

The most difficult aspect of implementation was changing the culture in the hospital, she added.

Support of leadership team members who advocated for change was key to achieving that. Regular audits to review outcomes and make changes as needed to achieve the intended benefit were also important, she noted.

As for readmissions, the numbers overall were small, and their relation to ERAS is questionable and something that is still being tracked and assessed, she said.

Pages

Recommended Reading

Survey: Litigation fears drive response to FDA power morcellator warnings
MDedge Family Medicine
VIDEO: Andexanet alfa effectively reverses factor Xa anticoagulant
MDedge Family Medicine
FDA updates breast implant–associated lymphoma cases, risk
MDedge Family Medicine
Same-day discharge for hysterectomy
MDedge Family Medicine
Sling revisions: pain as indication linked with SUI recurrence
MDedge Family Medicine
Study: No increased risk of serious AEs with combined urogyn/gyn onc surgery
MDedge Family Medicine
Fast-track catheter management offers little benefit after benign hysterectomy
MDedge Family Medicine
Life and health are not even across the U.S.
MDedge Family Medicine
Complication rates rise after decline in uterine fibroid morcellation
MDedge Family Medicine
Study: Preop EKGs have little utility for benign hysterectomy
MDedge Family Medicine